215 related articles for article (PubMed ID: 23927519)
1. Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor.
Capelli AM; Bruno A; Entrena Guadix A; Costantino G
J Med Chem; 2013 Sep; 56(17):7003-14. PubMed ID: 23927519
[TBL] [Abstract][Full Text] [Related]
2. Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach.
Rathnayake S; Weerasinghe S
J Mol Model; 2018 Nov; 24(12):342. PubMed ID: 30460461
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the glucocorticoid receptor ligand binding domain.
Bledsoe RK; Stewart EL; Pearce KH
Vitam Horm; 2004; 68():49-91. PubMed ID: 15193451
[TBL] [Abstract][Full Text] [Related]
4. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.
Charmandari E; Kino T; Ichijo T; Jubiz W; Mejia L; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2007 Oct; 92(10):3986-90. PubMed ID: 17635946
[TBL] [Abstract][Full Text] [Related]
5. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
[TBL] [Abstract][Full Text] [Related]
6. Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations.
Liu YL; Jang S; Wang SM; Chen CH; Li FY
J Biomol Struct Dyn; 2016 Jun; 34(6):1214-31. PubMed ID: 26198481
[TBL] [Abstract][Full Text] [Related]
7. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
McMaster A; Ray DW
Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of glucocorticoid receptor signaling.
Labeur M; Holsboer F
Medicina (B Aires); 2010; 70(5):457-62. PubMed ID: 20920967
[TBL] [Abstract][Full Text] [Related]
9. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
Schäcke H; Rehwinkel H; Asadullah K; Cato AC
Exp Dermatol; 2006 Aug; 15(8):565-73. PubMed ID: 16842594
[TBL] [Abstract][Full Text] [Related]
10. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
Charmandari E; Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the structural basis for glucocorticoid resistance caused by missense mutations in the ligand binding domain of glucocorticoid receptor.
Monteiro LLS; Franco OL; Alencar SA; Porto WF
J Mol Graph Model; 2019 Nov; 92():216-226. PubMed ID: 31401440
[TBL] [Abstract][Full Text] [Related]
12. Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1).
McMahon SK; Pretorius CJ; Ungerer JP; Salmon NJ; Conwell LS; Pearen MA; Batch JA
J Clin Endocrinol Metab; 2010 Jan; 95(1):297-302. PubMed ID: 19933394
[TBL] [Abstract][Full Text] [Related]
13. On the trail of the glucocorticoid receptor: into the nucleus and back.
Vandevyver S; Dejager L; Libert C
Traffic; 2012 Mar; 13(3):364-74. PubMed ID: 21951602
[TBL] [Abstract][Full Text] [Related]
14. Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α.
Onnis V; Kinsella GK; Carta G; Fayne D; Lloyd DG
Future Med Chem; 2009 Jun; 1(3):483-99. PubMed ID: 21426128
[TBL] [Abstract][Full Text] [Related]
15. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
16. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination.
Martinez ED; Pattabiraman N; Danielsen M
Exp Cell Res; 2005 Aug; 308(2):320-33. PubMed ID: 15936754
[TBL] [Abstract][Full Text] [Related]
18. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
[TBL] [Abstract][Full Text] [Related]
20. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
